The Moderna pharmaceutical company announced today that it expects to offer its Covid-19 vaccine at a price of between $ 32 and $ 37 per dose, a “pandemic price”, which will depend on the volume requested by each country and hopes to guarantee its universal access.
“We are working with governments around the world and with others to ensure that the vaccine is accessible regardless of the ability to pay,” Moderna CEO Stephane Bancel said in a call with investors.
The price will be lower for those countries that request large volumes of doses, said the company, who clarified that a “small” order, for which the price bracket announced today would apply, would be of the order of several million doses.
Moderna’s announcement came at the presentation of the second quarter results of the year, in which the Massachusetts-based company multiplied its revenue by five to $ 66.4 million.
At the end of July, Moderna had already received $ 400 million in deposits to supply the mRNA-1273 vaccine, the distribution of which is already negotiating with several interested countries.